Patients on warfarin who present with major bleeding or who need urgent surgery require rapid correction of their raised INR. The two mainstays are four-factor prothrombin complex concentrate (PCC) and fresh frozen plasma (FFP), each dosed by body weight and, for PCC, by the presenting INR.
How it works
Fresh frozen plasma is dosed by a simple weight rule:
FFP volume = 15 mL/kg
FFP units = FFP volume / unit volume (~250 mL)Four-factor PCC is dosed from an INR-banded weight rule that mirrors manufacturer labelling:
INR 2 to <4 -> 25 IU/kg
INR 4 to 6 -> 35 IU/kg
INR > 6 -> 50 IU/kg
dose = band x min(weight, 100 kg)The body weight is usually capped near 100 kg and the dose by the maximum studied total. Both products are factor top-ups, so intravenous vitamin K must accompany them to keep the INR down once the infused factors wear off.
Understanding the clinical context
Why INR matters for dosing PCC
The INR represents the degree of anticoagulation and reflects the depletion of vitamin K-dependent clotting factors (II, VII, IX, X) caused by warfarin. A higher INR means more factor depletion, and therefore more concentrate is needed to bring the patient to a target INR (usually 1.5 or below for major bleeding or urgent surgery). The three INR bands in the PCC dosing table — below 4, 4 to 6, and above 6 — correspond to stepwise increases in factor deficit.
Why vitamin K is non-negotiable
Both FFP and PCC provide a temporary depot of clotting factors but do not address the underlying cause: warfarin is still present, still inhibiting vitamin K epoxide reductase, and still blocking new factor synthesis. As the infused factors are consumed or degraded (factor VII has a half-life of around 4–6 hours), the INR will rebound unless intrinsic factor production is restored. Intravenous vitamin K (typically 5–10 mg) works over several hours to restore the enzyme pathway and sustain the reversal.
In clinical practice, PCC or FFP plus IV vitamin K is the standard approach for major bleeding reversal. Using PCC or FFP alone without vitamin K is appropriate only for an extreme emergency where administration must be immediate and vitamin K has not yet been prepared.
Choosing between FFP and PCC
| Parameter | FFP | Four-factor PCC |
|---|---|---|
| Onset of action | 30–60 min (includes thaw time) | 10–15 min (if pre-thawed or lyophilised) |
| Volume required (70 kg patient) | ~1,050 mL (4–5 units) | ~25 mL |
| Volume overload risk | Significant, especially elderly | Minimal |
| ABO compatibility | Required | Not required |
| Availability | Most hospitals | Specialist or emergency stock |
| Thrombosis risk | Low | Slightly higher (monitor post-dose) |
PCC is the preferred agent in most high-income clinical guidelines for warfarin reversal in major bleeding. FFP remains an option where PCC is unavailable, or in situations where a broader replacement of clotting factors is also needed (not just vitamin K-dependent factors).
Notes and cautions
PCC corrects the INR within minutes and avoids the large volume load of FFP, which is why guidelines favour it for life-threatening bleeding. The banded doses here are the values most commonly quoted on PCC labels, but products differ and some centres use a fixed-dose strategy regardless of INR. FFP carries a real risk of transfusion-associated circulatory overload at the volumes required, particularly in older or cardiac patients.
Post-reversal INR should be checked within 15–30 minutes after PCC to confirm the target has been achieved; if the INR remains above 1.5, a second dose may be considered per the product label and local protocol.
This calculator is for education and bedside cross-checking only. Confirm every dose against the product label and your institution’s haematology or anticoagulation protocol.